e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
24.90
-0.09 (-0.36%)
Official Closing Price
Updated: 7:00 PM EST, Dec 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
29,409,970
Open
24.97
Bid (Size)
24.89 (2,400)
Ask (Size)
24.90 (1,500)
Prev. Close
24.99
Today's Range
24.88 - 25.02
52wk Range
20.91 - 27.69
Shares Outstanding
5,606,688,356
Dividend Yield
6.91%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Great Rebound: US M&A Poised for Record-Breaking 2026 as Interest Rates Stabilize
Today 17:32 EST
As the calendar turns to January 1, 2026, the United States financial markets are witnessing a dramatic transformation in the landscape of corporate dealmaking. After a multi-year "deal desert"...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Pfizer’s Dividend Trap or Deep Value? Analyzing the Pharma Giant as Shares Languish Below $30
Today 14:13 EST
As the calendar turns to January 1, 2026, Pfizer Inc. (NYSE: PFE) finds itself in a position that would have been unthinkable during the height of the pandemic. Once the darling of the pharmaceutical...
Via
MarketMinute
Topics
Intellectual Property
Performance
YTD
N/A
N/A
1 Month
-1.5%
-1.5%
3 Month
-8.5%
-8.5%
6 Month
-1.7%
-1.7%
1 Year
-6.1%
-6.1%
More News
Read More
Economic Revolution or Looming Recession? Trump’s ‘A++’ Claims Clash with Wall Street’s Cautious 2026 Outlook
Today 14:07 EST
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
Should You Buy Pfizer While It's Under $30?
↗
Today 12:57 EST
Via
The Motley Fool
Topics
Government
Intellectual Property
World Trade
Investing $122,100 in These 3 High-Yield Dividend Stocks Could Make You $10,000 in Reliable Passive Income in 2026
↗
Today 5:04 EST
Via
The Motley Fool
1 Momentum Stock to Target This Week and 2 That Underwhelm
December 31, 2025
Via
StockStory
Where Will Pfizer Be in 5 Years?
↗
December 31, 2025
Via
The Motley Fool
Topics
Intellectual Property
The Metabolic Squeeze: Big Pharma’s 2025 Defined by $1 Trillion Valuations and Regulatory Reckonings
December 31, 2025
Via
MarketMinute
Topics
Economy
Intellectual Property
Law Enforcement
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
December 31, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Why Wall Street Gave Up on Pfizer—and Why That May Be a Mistake
↗
December 31, 2025
Via
MarketBeat
2 Unstoppable Dividend Stocks to Double Up on Right Now
↗
December 31, 2025
Via
The Motley Fool
Pfizer Leads New Wave Of 2026 US Drug Price Hikes Despite Trump’s Drug Cost Crackdown: Report
↗
December 31, 2025
Via
Stocktwits
Topics
Economy
Government
Tuesday's session: most active stock in the S&P500 index
↗
December 30, 2025
Via
Chartmill
The Trillion-Dollar Shuffle: How Year-End Institutional Rebalancing is Fueling Late-December Volatility
December 30, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
ETFs
The Great Consolidation: Why 2026 is Set to Become the Year of the Mega-Deal
December 30, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Hunterbrook Capital Bets Big on Achieve Life Sciences: Why a 'Toxic Tree' Could Disrupt the Multi-Billion Dollar Smoking Cessation Market
December 30, 2025
Via
MarketMinute
Topics
Product Recall
Achieve Life Sciences’ Smoking Treatment Likely To Be Approved By FDA, Says Hunterbrook
↗
December 30, 2025
Via
Stocktwits
Is Bristol Myers Squibb a Buy, Sell, or Hold in 2026?
↗
December 30, 2025
Via
The Motley Fool
Topics
Intellectual Property
The 2026 Income Fortress: Why Big Pharma is the Defensive Play of the New Year
December 30, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Want $300 in Super-Safe Dividend Income in 2026? Invest $2,670 Into the Following 3 Ultra-High-Yield Stocks.
↗
December 30, 2025
Via
The Motley Fool
Stay informed about the most active stocks in the S&P500 index on Monday's session.
↗
December 29, 2025
Via
Chartmill
The Trillion-Dollar Apothecary: Inside Eli Lilly’s Era of Metabolic Dominance
December 29, 2025
Via
PredictStreet
Topics
Earnings
Economy
Intellectual Property
The Smartest Dividend Stocks to Buy With $3,000 Right Now
↗
December 28, 2025
Via
The Motley Fool
3 Drug Stocks to Buy at a Discount
↗
December 27, 2025
Via
The Motley Fool
Topics
Intellectual Property
3 Superb High-Yield Dividend Stocks With Yields North of 5% That Make for No-Brainer Buys Right Now
↗
December 27, 2025
Via
The Motley Fool
Frequently Asked Questions
Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 24.90
When was Pfizer last traded?
The last trade of Pfizer was at 12/31/25 07:00 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 139.61B
How many shares of Pfizer are outstanding?
Pfizer has 140B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
wpDiscuz
Insert